Dr@Home

Insulin resistance, type 2 diabetes, and metabolic syndrome are major and escalating global health problems. Key factors driving these issues include obesity, unhealthy lifestyles, and genetic predispositions. These conditions place a significant burden on individuals and healthcare systems due to morbidity, mortality, and healthcare costs. Effective prevention and management strategies rely on lifestyle modifications, early diagnosis and, in some cases, medication. The continued collection of data and further research on the underlying mechanisms will be essential to combat these complex challenges effectively.

Sources and links:

Thanks again for tuning in. Follow for more. Instagram: ⁠⁠⁠⁠⁠⁠⁠sckvvv_drathome⁠⁠⁠⁠⁠⁠⁠; YouTube: ⁠⁠⁠⁠⁠⁠⁠@DrSean-888.⁠⁠⁠⁠

Disclaimer

The information presented in this podcast is for informational and educational purposes only and not as medical advice. While every effort has been made to ensure accuracy and relevance, the content is not exhaustive nor guaranteed to remain current beyond the date of recording. The perspectives shared reflect research and opinions as of the time of production.

Listeners are encouraged to conduct their own independent research into these topics, where necessary, and if concerned or distressed by anything discussed in this episode, please consult your Dr or Healthcare Team. The creator of this podcast assumes no liability for any actions taken based on the content presented.

Today we discuss an experience I had with an at-home blood sample collection process for the T1DRA study, a UK-based research initiative investigating type 1 diabetes risk factors in adults. The study aims to identify individuals at increased risk and improve understanding of the condition's development. Participants aged 18-70 provide blood samples, and those with multiple risk markers receive information on type 1 diabetes management and clinical trials. The accompanying video is available on YouTube here and details the sample collection procedure, offering timestamps for viewers' convenience. The study seeks diverse participation to ensure representative findings for the general UK adult population. An unboxing of the study material received can be accessed here.

Although my concerns are about acquiring T2DM, I felt it necessary to partake in this T1DM study. Links available on my YouTube channel.

Thanks again for tuning in. Follow for more. Instagram: ⁠⁠⁠⁠⁠⁠sckvvv_drathome⁠⁠⁠⁠⁠⁠; YouTube: ⁠⁠⁠⁠⁠⁠@DrSean-888.⁠⁠⁠

Disclaimer

The information presented in this podcast is for informational and educational purposes only and not as medical advice. While every effort has been made to ensure accuracy and relevance, the content is not exhaustive nor guaranteed to remain current beyond the date of recording. The perspectives shared reflect research and opinions as of the time of production.

Listeners are encouraged to conduct their own independent research into these topics, where necessary, and if concerned or distressed by anything discussed in this episode, please consult your Dr or Healthcare Team. The creator of this podcast assumes no liability for any actions taken based on the content presented.

Cystic fibrosis (CF) is a complex genetic disorder with significant implications for those affected. While there is currently no cure, advancements in our understanding of the disease, its genetic underpinnings, and the development of targeted therapies are improving both life expectancy and quality of life for those affected. Yet, many challenges remain especially on the metabolic adaptations of Pseudomonas aeruginosa (P. aeruginosa) during chronic infections in the lungs of individuals with Cystic Fibrosis (CF). These adaptations are not simply a consequence of the environment, but an active process driven by specific mutations and metabolic shifts that impact virulence, immune evasion and interactions within the CF lung. A key finding is that mutations in the PDHc, causing shifts in pyruvate metabolism, play a central role in driving this adaption. Further research into these metabolic changes is essential for developing more effective treatment strategies for CF-related infections. The use of advanced metabolomics, proteomics, and in vitro models is essential to understanding this dynamic process.

A few sources: https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002781⁠; https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2021.617784/full⁠⁠; ⁠https://www.sciencedirect.com/science/article/pii/S0966842X16000214⁠; https://pmc.ncbi.nlm.nih.gov/articles/PMC6835255/

Thanks for tuning in. Follow for more. Instagram: ⁠⁠⁠⁠⁠sckvvv_drathome⁠⁠⁠⁠⁠; YouTube: ⁠⁠⁠⁠⁠@DrSean-888.⁠⁠

Disclaimer

The information presented in this podcast is for informational and educational purposes only and not as medical advice. While every effort has been made to ensure accuracy and relevance, the content is not exhaustive nor guaranteed to remain current beyond the date of recording. The perspectives shared reflect research and opinions as of the time of production.

Listeners are encouraged to conduct their own independent research into these topics, where necessary, and if concerned or distressed by anything discussed in this episode, please consult your Dr or Healthcare Team. The creator of this podcast assumes no liability for any actions taken based on the content presented.

Cystic fibrosis (CF) is a complex genetic disorder with significant implications for those affected. While there is currently no cure, advancements in our understanding of the disease, its genetic underpinnings, and the development of targeted therapies like CFTR modulators are improving both life expectancy and quality of life for those affected. Ongoing research into gene therapy, modifier genes and personalized medicine holds much promise for the future management of CF.

A few sources: https://www.nhs.uk/conditions/cystic-fibrosis/; https://my.clevelandclinic.org/health/diseases/9358-cystic-fibrosis; https://www.nhlbi.nih.gov/health/cystic-fibrosis/living-with; https://pmc.ncbi.nlm.nih.gov/articles/PMC4364438/

Thanks for tuning in. Follow for more. Instagram: ⁠⁠⁠⁠sckvvv_drathome⁠⁠⁠⁠; YouTube: ⁠⁠⁠⁠@DrSean-888.⁠

Disclaimer

The information presented in this podcast is for informational and educational purposes only and not as medical advice. While every effort has been made to ensure accuracy and relevance, the content is not exhaustive nor guaranteed to remain current beyond the date of recording. The perspectives shared reflect research and opinions as of the time of production.

Listeners are encouraged to conduct their own independent research into these topics, where necessary, and if concerned or distressed by anything discussed in this episode, please consult your Dr or Healthcare Team. The creator of this podcast assumes no liability for any actions taken based on the content presented.

This episode consolidates information from four distinct sources: a laboratory assignment on cellular pathology, NICE guidelines on colorectal cancer, a journal article on small bowel adenocarcinoma (SBA), and treatment options from Cancer Research UK. It aims to provide an overview of relevant concepts, diagnostic techniques, and treatment strategies, with a focus on the pathology of gastrointestinal cancers. Links below:

https://www.nice.org.uk/guidance/ng151/chapter/Recommendations; https://pmc.ncbi.nlm.nih.gov/articles/PMC8918997/; https://www.cancerresearchuk.org/about-cancer/small-bowel-cancer/treatment

Thanks for tuning in. Follow for more. Instagram: ⁠⁠⁠sckvvv_drathome⁠⁠⁠; YouTube: ⁠⁠⁠@DrSean-888.

Disclaimer

The information presented in this podcast is for informational and educational purposes only and not as medical advice. While every effort has been made to ensure accuracy and relevance, the content is not exhaustive nor guaranteed to remain current beyond the date of recording. The perspectives shared reflect research and opinions as of the time of production.

Listeners are encouraged to conduct their own independent research into these topics, where necessary, and if concerned or distressed by anything discussed in this episode, please consult your Dr or Healthcare Team. The creator of this podcast assumes no liability for any actions taken based on the content presented.

The convergence of AI and structural biology is revolutionising how researchers investigate complex biological and biomedical problems. By applying these techniques to their research, scientists are closer to developing novel therapeutic strategies and preventative measures. While AI offers an immense acceleration to the generation of hypotheses and models, it should not be seen as a replacement for traditional experimental techniques and the valuable insight that they bring.

NB. My research (MRes and PhD) at Imperial College London during 2012 to 2021 centred around protein crystallisation methodologies and x-ray crystallography, which aided 3-D protein structures determination. Data and information gained from crystallography is vital to the success of rational drug design and medicinal therapeutics and biotechnological applications. If AlphaFold existed in its current form during parts of my research period, I'm positive it would have helped accelerate the painstaking research we conducted and potentially helped boost our findings and results. Selected research below:

⁠https://www.nature.com/articles/srep20053; https://journals.iucr.org/m/issues/2021/04/00/mf5053/index.html⁠; https://pmc.ncbi.nlm.nih.gov/articles/PMC2670972/⁠; ⁠https://deepmind.google/technologies/alphafold/⁠; ⁠https://www.nature.com/articles/s41586-021-03819-2⁠; https://www.nature.com/articles/s41592-023-02087-4⁠

Thanks for tuning in. Follow for more. Instagram: ⁠⁠⁠⁠sckvvv_drathome⁠⁠⁠⁠; YouTube: ⁠⁠⁠⁠@DrSean-888.

Disclaimer

The information presented in this podcast is for informational and educational purposes only. While every effort has been made to ensure accuracy and relevance, the content is not exhaustive nor guaranteed to remain current beyond the date of recording. The perspectives shared reflect research and opinions as of the time of production.

Listeners are encouraged to conduct their own independent research into these topics, where necessary. The creator of this podcast assumes no liability for any actions taken based on the content presented.

The convergence of AI and structural biology is revolutionising how researchers investigate complex biological problems. By applying these techniques to HIV research, scientists are closer to developing novel therapeutic strategies and preventative measures. While AI offers an immense acceleration to the generation of hypotheses and models, it should not be seen as a replacement for traditional experimental techniques and the valuable insight that they bring.

NB. My research (MRes and PhD) at Imperial College London during 2012 to 2021 centred around protein crystallisation methodologies and x-ray crystallography, which aided 3-D protein structures determination. Data and information gained from crystallography is vital to the success of rational drug design and medicinal therapeutics and biotechnological applications. If AlphaFold existed in its current form during my research period, I'm positive it would have helped accelerate the painstaking research we conducted and potentially helped boost our anti-CCR5 RoAb13-Peptide Complex diffraction of 3.2 - 3.36 Å to a higher resolution. Research below:

https://journals.iucr.org/m/issues/2021/04/00/mf5053/index.html https://pmc.ncbi.nlm.nih.gov/articles/PMC2670972/ https://deepmind.google/technologies/alphafold/ https://www.nature.com/articles/s41586-021-03819-2 https://www.nature.com/articles/s41592-023-02087-4

Thanks for tuning in. Follow for more. Instagram: ⁠⁠⁠⁠sckvvv_drathome⁠⁠⁠⁠; YouTube: ⁠⁠⁠⁠@DrSean-888.

Listeners are encouraged to conduct their own independent research into these topics, where necessary. The creator of this podcast assumes no liability for any actions taken based on the content presented.

Welcome back, Everyone. Today we continue our journey into Higher Education and Advanced Degrees.

Today, Jack and Jill, continue their conversation on the topic which I have researched and compiled. Part 4 follows on Parts 1 (Dr Titles), 2 (Doctorates), and 3 (Masters), already covered on this channel. Feel free to check them out.

Part 4 tracks back a bit into the Masters degree evolution and whilst overlapping with some themes from Part 3, we delve deeper into MBAs, leadership skills training; consulting and business requirements, etc. In addition, we look at costs, risks, and market trends of pursuing an Advanced Degree.

Any thoughts, insights, and comments, feel free to post them in the comment section.

Thanks for tuning in. Follow for more. Instagram: ⁠⁠⁠sckvvv_drathome⁠⁠⁠; YouTube: ⁠⁠⁠@DrSean-888.

Disclaimer
The information presented in this podcast is for informational and educational purposes only. While every effort has been made to ensure accuracy and relevance, the content is not exhaustive nor guaranteed to remain current beyond the date of recording. The perspectives shared reflect research and opinions as of the time of production.

Listeners are encouraged to conduct their own independent research and seek professional advice where necessary. The creator of this podcast assumes no liability for any actions taken based on the content presented.

Up next we cover Part 3 of our look into Higher Education and Advanced Degrees. Join Jack and Jill in this episode as they discuss Master degree programmes and its evolution, drawing upon multiple sources to explore their history, types, purpose, and implications for career progression. We aim to provide a general understanding of their role in both personal and professional development, and the considerations surrounding their pursuit.

Part 1 and Part 2 in the series are available on my channel. Check it out.

Any thoughts and comments, feel free to post them in the comment section.

Thanks for tuning in. Follow for more. Instagram: ⁠⁠sckvvv_drathome⁠⁠; YouTube: ⁠⁠@DrSean-888.

Disclaimer
The information presented in this podcast is for informational and educational purposes only. While every effort has been made to ensure accuracy and relevance, the content is not exhaustive nor guaranteed to remain current beyond the date of recording. The perspectives shared reflect research and opinions as of the time of production.

Listeners are encouraged to conduct their own independent research and seek professional advice where necessary. The creator of this podcast assumes no liability for any actions taken based on the content presented.

Following on from the Part 1, we now explore the world of PhDs (Doctor of Philosophy). We consolidate findings from multiple sources to provide an overview of the current state of PhD education globally. We examine trends in Doctoral recipients, funding, international mobility, and challenges within specific regions, highlighting the complexity and diverse nature of Doctoral studies.

Key Themes

Global PhD Production & Distribution; Gender Balance; International Student Mobility; COVID-19 Pandemic; Funding of PhD Studies; Subject Areas & Post-Graduation Trends; Global Inequality; Challenges & Regional Issues; Transnational Education (TNE) & Split-Site Programmes

Key Points

- The United States awards the world's largest number of Doctorates, approximately 71,000 per year.

- Overall, approximately 277,000 Doctoral degrees are awarded worldwide each year.

- In the past 20 years, female Doctorate recipients in S&E fields increased by 91%, compared with a 57% increase in male S&E Doctorate recipients.

- The UK is losing ground to Germany and Canada in attracting international Doctoral studies

- Non-EU PGR entrants, especially from China, have been driving the UK’s overall recruitment performance.

- There was a significant increase in the number of self-funded entrants in 2020–21.

- On average, only 1 per cent of the world’s 25-64 year olds who have been to university, have a PhD.

Conclusion

The global PhD landscape is characterised by significant variations in production, gender balance, funding, and international mobility. While some regions and institutions are thriving, others are struggling to produce the necessary number of PhD holders for their needs. The trends suggest a need for increased investment, better support systems, and more equitable access to Doctoral studies worldwide, as well as an understanding of how the PhD degree can be better utilised in society.

Thank you for listening. Follow for more. Instagram: ⁠sckvvv_drathome⁠; YouTube: ⁠@DrSean-888.

Disclaimer
The information presented in this podcast is for informational and educational purposes only. While every effort has been made to ensure accuracy and relevance, the content is not exhaustive nor guaranteed to remain current beyond the date of recording. The perspectives shared reflect research and opinions as of the time of production.

Listeners are encouraged to conduct their own independent research and seek professional advice where necessary. The creator of this podcast assumes no liability for any actions taken based on the content presented.